

Cover Story
FDA will hold a three-day meeting of the Oncologic Drugs Advisory Committee April 27-29 to consider five indications that received accelerated approvals, but that have not been shown to produce a clinical benefit in confirmatory trials.
In Brief
Clinical Roundup


Drugs & Targets


Trending Stories
- UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil
- Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it
- Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die
- Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation
- Sexual harassers should face consequences: As NIH director, Bertagnolli can foster change
- Ezra Cohen named chief medical officer of oncology at Tempus